FinTechFunding

EVerZom: Raises €1.1M in Funding

  • EVerZom, a Paris, France-based biopharmaceutical company specialized in the bioproduction of exosomes, raised €1.1m in funding
  • Backers also included institutional and private investors
  • This funding will also speed up the platform development and scale-up, to allow routine clinical-grade production by 2022
  • Led by Jeanne Volatron, Co-founder and President, EVerZom is to develop an exosome bioproduction platform
  • Exosomes are biological nanoparticles released by cells as an intercellular communication system to transport biomolecules
  • They have the ability to deliver therapeutics or regenerate tissue in several pathologies, including osteoarthritis, heart failure
Previous article
RotoGro International: Signs long-term licence agreement
Next article
Flock Freight: Raises $113.5M in Series C Funding
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

Kulipa Secures $62M to Enhance Stablecoin Card Issuing Infrastructure

Funding aims to strengthen cryptocurrency card services in the growing fintech market.Highlights: Kulipa raises $62M to enhance its...
FinTech

Visa Launches AI-Powered Dispute Resolution Tools

New tools aim to streamline resolution of payment disputes.Highlights: Visa introduces AI tools for payment dispute resolution.The new...
FinTech

UK Fintechs Vibepay and SmartLayer Shut Down

Both companies cease operations amidst challenging market conditions.Highlights: Vibepay and SmartLayer have officially ceased operations.The closures are attributed...
FinTech

Visa and Ramp Boost Bill Pay Automation with Agentic AI

New integration aims to streamline corporate expense management processes.Highlights: Visa and Ramp announce partnership to automate corporate bill...